# Network Osteoporosis Study

> **NCT00209469** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Glaser Pediatric Research Network** · enrollment: 90 (—)

## Conditions studied

- Osteopenia
- Osteoporosis

## Interventions

- **DRUG:** alendronate sodium

## Key facts

- **NCT ID:** NCT00209469
- **Lead sponsor:** Glaser Pediatric Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-07
- **Primary completion:** —
- **Final completion:** 2007-02
- **Target enrollment:** 90 (—)
- **Last updated:** 2005-09-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00209469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00209469, "Network Osteoporosis Study". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00209469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*